China's biotech firm Ascletis attracts $400M in HK IPO

Note: This section contains information in English only.
Source: Dukascopy Bank SA
China's biotech Ascletis Pharma has raised $400M after it had priced its Hong Kong initial public offering of the indicative range.
Back to articles

Actual Topics

Thu, 26 Jul 2018 07:54:06 GMT

ANZ plans controlling stake sale in pensions business for $596M

On Thursday, Australia & New Zealand Banking Group stated it had agreed to sell 82% in the pensions business P&I and ADG to the wealth manager IOOF in a deal worth $596M.

Thu, 26 Jul 2018 06:39:30 GMT

Nine acquires Fairfax in deal worth $1.6B

On Thursday, Fairfax Media agreed to a $1.6B buyout from the TV network Nine Entertainment in one of the largest shake-ups of the Australian media recently.

Subscribe to "Fundamental Analysis" feed

Subscribe
Per scoprire di più sulla piattaforma di Dukascopy Bank per Forex/CFD, sul SWFX ed altre informazioni relative al trading,
la preghiamo di contattarci o richiedere di essere contattato (callback request)
For further information regarding potential cooperation,
please call us or make callback request.
To learn more about Dukascopy Bank Binary Options / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
Per scoprire di più sulla piattaforma di Dukascopy Bank per Forex/CFD, sul SWFX ed altre informazioni relative al trading,
la preghiamo di contattarci o richiedere di essere contattato (callback request).
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Business Introducer and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.